Skip to content

ABT

Abbott Laboratories

Shareholders' equity, 2025
$52.1B
YoY, 2025
+9.4%
5-year CAGR
+9.7%
10-year CAGR
+9.4%

Shareholders' equity

Shareholders' equity by fiscal year

PeriodEquityYoY
2025$52.1B+9.4%
2024$47.7B+23.5%
2023$38.6B+5.2%
2022$36.7B+2.5%
2021$35.8B+9.2%
2020$32.8B+5.5%
2019$31.1B+1.8%
2018$30.5B−1.2%
2017$30.9B+50.4%
2016$20.5B−3.2%
2015$21.2B−1.5%
2014$21.5B−14.5%
2013$25.2B−5.8%
2012$26.7B+9.3%
2011$24.4B+7.8%
2010$22.7B−2.0%
2009$23.1B+32.4%
2008$17.5B−1.7%
2007$17.8B—